Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ascophyllum nodosum is a brown macroalga (seaweed) widely utilized in agriculture, animal nutrition, and human health. As a biostimulant, its extracts enhance crop yield and resilience against abiotic stresses like salinity, drought, and heavy metal toxicity by modulating physiological and biochemical pathways, including antioxidant defense and nutrient uptake. In animal health, it is used as a feed additive to mitigate methane emissions in ruminants, improve iodine metabolism in dairy cows, and provide anti-inflammatory benefits (via fucoidans) in conditions like canine chronic inflammatory enteropathy. Its bioactive constituents include sulfated polysaccharides (fucoidans), phlorotannins (polyphenols), and minerals, which exhibit antioxidant, anticoagulant, and prebiotic properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ascophyllum nodosum.